Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gore, IN

Archishmat Sharad Gore, Hyderabad IN

Patent application numberDescriptionPublished
20090006075PHONETIC SEARCH USING NORMALIZED STRING - A method and system for generating a normalized string and performing a phonetic search are provided. To normalize a string, a native string is obtained. Upon obtaining a native string, native-character sets within the native string are identified. Each native-character set is associated with a phonetically corresponding normalized character-set. A normalized string is generated based on the phonetically corresponding normalized character-sets. After normalizing a query string and one or more search content strings, the normalized strings may be utilized to perform a phonetic search. As such, the query string may be compared to the one or more search content strings to ascertain relevant search results. Relevant search results may be indexed and obtained at a later instant.01-01-2009

Dhananjay Gore, Bangalore IN

Patent application numberDescriptionPublished
20120026959INTER-SECTOR CONTROL CHANNEL TRANSMISSION - Provided is a more efficient manner of transmitting a control message to reach into a neighboring sector (e.g., inter-sector) of a wireless network environment. The control message can be utilized for purposes such as handoff, indicating an amount of interference, inter-sector power control for managing inter-sector interference, sector loading, or other control messages. The control message can be placed on a set of resources utilizing planned reuse and/or statistical reuse. Statistical reuse includes selecting a subcarrier set for carrying the control message. According to some aspects, the control message can be sent over a backhaul channel.02-02-2012

Dhananjay Ashok Gore, Bangalore IN

Patent application numberDescriptionPublished
20120063369METHOD AND APPARATUS FOR MITIGATING RELAY INTERFERENCE - Methods and apparatuses are provided that include selecting resources for assigning to a device to mitigate relay self-interference when also communicating with a base station. The resources can be selected based on one or more factors, such as based on resources that are negotiated with the base station, or based on resources indicated as not desired for allocation from the base station, etc. In other examples, reference signals and control data can be communicated such as to mitigate relay self-interference as well.03-15-2012
20120063492METHOD AND APPARATUS OF OBTAINING TIMING IN A REPEATER - Methods and apparatuses are provided that include a mobile station modem (MSM) embedded in a repeater for enhancing repeater functionality. The MSM can determine a timing of a base station based on one or more signals received therefrom. Using the timing, the repeater can align timing to that of the base station, determine cyclic prefix of the received signals, cancel echo from received signals, switch between receiving uplink and downlink signals, transmit PRSs according to the timing, and/or the like.03-15-2012

Sharad Gore, Thane IN

Patent application numberDescriptionPublished
20110105619AMORPHOUS BUPROPION HYDROBROMIDE AND PREPARATION THEREOF - The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation.05-05-2011

Subhash Gore, Sholapur IN

Patent application numberDescriptionPublished
20090202649FENOFIBRATE FORMULATIONS - The present invention relates to pharmaceutical formulations comprising fenofibrate. The invention also relates to stable and bioavailable pharmaceutical formulations comprising fenofibrate. Further the invention also relates to processes for preparing the compositions and/or formulations of fenofibrate and their methods of use, treatment and administration.08-13-2009
20090232897PHARMACEUTICAL COMPOSITIONS COMPRISING CONJUGATED ESTROGENS - Pre-mix compositions containing conjugated estrogens and a pharmaceutical carrier, and pharmaceutical formulations containing a pre-mix composition. Further, the invention includes processes for preparing the premix compositions and pharmaceutical formulations containing pre-mix compositions.09-17-2009

Subhash Gore, Secunderabad IN

Patent application numberDescriptionPublished
20110020456LANTHANUM COMPOSITION - The present invention discloses stable, solid oral pharmaceutical composition comprising Lanthanum carbonate having more than 6 molecules of water per molecule of lanthanum carbonate and pharmaceutically acceptable carriers or diluents, wherein said carrier or diluent excludes monosaccharide/s or disaccharide/s, such that the composition has comparable in-vitro dissolution profile similar to that of FOSRENOL®.01-27-2011

Subhash Pandurang Gore, Hyderabad IN

Patent application numberDescriptionPublished
20080206329Modified Release Ciprofloxacin Compositions - Controlled release tablets comprising ciprofloxacin, with hardness and friability of the said tablets ranges between 10 to 70 kiloponds and less than 2% respectively, the compositions releasing at least 80 percent of the total amount of the ciprofloxacin into a pH 1.2 aqueous dissolution medium within about 1 hour.08-28-2008

Subhash Pandurang Gore, Solapur IN

Patent application numberDescriptionPublished
20090028944PHARMACEUTICAL COMPOSITIONS COMPRISING MESALAMINE - Pharmaceutical compositions comprising mesalamine, wherein the compositions are free of a liphophilic matrix, and processes for preparing pharmaceutical compositions comprising mesalamine and being free of a liphophilic matrix.01-29-2009
20090124657PHARMACEUTICAL COMPOSITIONS COMPRISING MONTELUKAST - Pharmaceutical compositions comprising montelukast or pharmaceutically acceptable salts, solvates, polymorphs, enantiomers or mixtures thereof.05-14-2009

Vikas Gore, Ahmednagar IN

Patent application numberDescriptionPublished
20090156604FUSED BICYCLIC IMIDAZOLES - Compounds of formula (I)06-18-2009

Vinayak Gore, Maharashtra IN

Patent application numberDescriptionPublished
20100292290NOVEL PROCESS TO PREPARE ALMOTRIPTAN - The present invention relates to a novel process for the preparation of almotriptan and pharmaceutically acceptable salts thereof, which affords product conveniently and efficiently with commercially acceptable yields and purity. The present invention also relates to a novel synthetic intermediate used in the process.11-18-2010
20110124909NOVEL PROCESS - The present invention relates to a novel process of preparing an enantiomerically enriched γ-amino acid, such as enantiomerically enriched (S)-pregabalin.05-26-2011
20110184071 PROCESS FOR THE PREPARATION OF AMINES - The present invention relates to an improved process for the preparation of rasagiline (1) and its pharmaceutically acceptable salts. In particular it relates to a process for preparing rasagiline (1) and its salts substantially free from impurities.07-28-2011
20110190393NOVEL AND EFFICIENT METHOD FOR THE SYNTHESIS OF AN AMINO ACID - The present invention relates to a novel process for the preparation of γ-amino acids, such as (±)-3-(aminomethyl)-5-methyl-hexanoic acid (1), which is a key intermediate in the preparation of the potent anticonvulsant pregabalin, (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid (2), and its analogues.08-04-2011
20110251288PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE AMINES - The present invention relates to an improved process for the preparation of (R)-1-aminoindan (2), rasagiline (1) and pharmaceutically acceptable salts of rasagiline.10-13-2011
20110257237PROCESS FOR THE PREPARATION OF CRYSTALLINE FORMS OF SUNITINIB MALATE - The present invention, relates to novel processes for the preparation of sunitinib malate formula (I), pharmaceutical compositions comprising said polymorph and the use of the said pharmaceutical compositions in the treatment of various forms of cancer.10-20-2011
20110263649CRYSTALLINE FORM OF LENALIDOMIDE AND A PROCESS FOR ITS PREPARATION - The present invention relates to a novel crystalline form of lenalidomide having formula (I) and chemically known as 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione. The present invention further relates to a process for the preparation of said novel form and its use in pharmaceutical preparations for the treatment of autoimmune disease, inflammation, inflammatory disease and diseases such as cancer, in particular the management of multiple myeloma.10-27-2011
20110263670NOVEL POLYMORPHS OF SUNITINIB AND PROCESSES FOR THEIR PREPARATION - The present invention relates to novel polymorphs of sunitinib free base designated form II and form III and to processes for their preparation. The invention also relates to their use as APIs and in the preparation of various forms of sunitinib. Further, the invention relates to pharmaceutical compositions comprising said novel polymorphs and salts, solvates and hydrates prepared according to the invention, and to the uses of said pharmaceutical compositions in the treatment and/or prevention of cancer.10-27-2011
20110263713POLYMORPHS - The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions. Formula (I).10-27-2011
20110263718PROCESS FOR THE PREPARATION OF O-DESMETHYLVENLAFAXINE - The present invention provides a convenient and efficient process for the preparation of O-desmethylvenlafaxine (ODV) or a salt thereof, comprising the reaction of venlafaxine, or a salt thereof, with a thiourea or a mixture of thioureas.10-27-2011
20110263719POLYMORPHIC FORM OF RASAGILINE MESYLATE - The present invention relates to a novel crystalline form of rasagiline mesylate and a pure form of rasagiline mesylate and processes for their preparation. Further, the invention relates to pharmaceutical compositions comprising said forms and use of said compositions in the treatment of patients suffering from Parkinson's Disease, dementia, Alzheimer's Disease, depression, hyperactive syndrome, stroke, brain ischemia, neurotrauma, schizophrenia and multiple sclerosis.10-27-2011
20110269838NOVEL PROCESSES AND PURE POLYMORPHS - The present invention relates to crystalline forms of the active pharmaceutical ingredient vorinostat, processes for their preparation and their use in pharmaceutical compositions.11-03-2011
20120029046CRYSTALLINE FORM OF SUNITINIB AND PROCESSES FOR ITS PREPARATION - The present invention relates to a novel crystalline form of sunitinib free base designated form I and to processes for its preparation. The invention also relates to its use as an API and in the preparation of various forms of sunitinib. Further, the invention relates to pharmaceutical compositions comprising the novel crystalline form and salts, solvates and hydrates prepared according to the invention, and to the uses of said pharmaceutical compositions in the treatment and/or prevention of cancer.02-02-2012

Patent applications by Vinayak Gore, Maharashtra IN

Vinayak Govind Gore, Maharashtra IN

Patent application numberDescriptionPublished
20110118357PROCESS FOR PREPARING O-DESMETHYLVENLAFAXINE - The present invention provides a convenient and efficient process for the preparation of O-desmethylvenlafaxine (ODV), comprising the reaction of venlafaxine, or a salt thereof, with a thiol reagent such as a dithiol, an aminothiol or an inorganic thiol. The present invention also provides a process for purifying ODV base, said process comprising the steps of mixing crude ODV base with an alcohol to form a suspension and adding acid followed by base to generate ODV base with high purity.05-19-2011